Back

CETP inhibition: lessons from two decades of clinical trials

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Innovating the clinical management of LDL-c: exploring CETP as therapeutic target Pharmacology and Pharmacotherapy Open Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Stephen Nicholls

Monash University, Melbourne (Australia)

4 More presentations in this session

Presentation thumbnail
Introduction
Professor K. Ray (London, GB)
Slides Video
Presentation thumbnail
What do we know now that could have changed the history of CETP Inhibition? Genetics and biology
Professor J. Kastelein (Amsterdam, NL)
Slides Video
Presentation thumbnail
A novel CETP-inhibitor to target CV risk reduction: where could it fit in future lipid management?
Professor E. Michos (Baltimore, US)
Slides Video
Presentation thumbnail
Discussion
Professor K. Ray (London, GB) Professor G. Norata (Milan, IT)
Video

Access the full session

Session thumbnail
Innovating the clinical management of LDL-c: exploring CETP as therapeutic target
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
What do we know now that could have changed the history of CETP Inhibition? Genetics and biology
thumbnail
Congress Presentation
Exploring the role of novel CETP inhibitors in lipid management
thumbnail
Congress Presentation
Cracking the code: the biology and mechanism of CETP inhibition

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources